Plantas medicinais no processo de cicatrização de feridas: uma revisão de literatura

Uma busca foi realizada na literatura, visando sumarizar as pesquisas realizadas e obter informações acerca da utilização de plantas medicinais no processo de cicatrização de feridas. Utilizaram-se os descritores: Plantas Medicinais e Cicatrização de Feridas e seus equivalentes em inglês e espanhol, com o operador booleano "AND" em três bases eletrônicas de dados (PubMed, LILACS e COCHRANE). Foram selecionados 57 artigos para compor a revisão. Os resultados apontam que um total de 52 plantas medicinais e um composto de ervas foram estudados experimentalmente ou clinicamente, quanto aos seus efeitos no auxílio do processo de cicatrização, sendo que a maioria (88,5%) apresentou eficácia. Com isso, verifica-se que a utilização de plantas medicinais trata de importante alternativa no tratamento de feridas, que começa a fazer parte da atenção à saúde brasileira, o que sugere novos estudos de comprovação clínica, custos, e benefícios e a constante atualização acerca das publicações realizadas

<a name="home"></a>Liver mitochondrial dysfunction and oxidative stress in the pathogenesis of experimental nonalcoholic fatty liver disease

Oxidative stress and hepatic mitochondria play a role in the pathogenesis of nonalcoholic fatty liver disease. The aim of the present study was to evaluate the role of hepatic mitochondrial dysfunction and oxidative stress in the pathogenesis of the disease. Fatty liver was induced in Wistar rats with a choline-deficient diet (CD; N = 7) or a high-fat diet enriched with PUFAs-omega-3 (H; N = 7) for 4 weeks. The control group (N = 7) was fed a standard diet. Liver mitochondrial oxidation and phosphorylation were measured polarographically and oxidative stress was estimated on the basis of malondialdehyde and glutathione concentrations. Moderate macrovacuolar liver steatosis was observed in the CD group and mild liver steatosis was observed in the periportal area in the H group. There was an increase in the oxygen consumption rate by liver mitochondria in respiratory state 4 (S4) and a decrease in respiratory control rate (RCR) in the CD group (S4: 32.70 ± 3.35; RCR: 2.55 ± 0.15 ng atoms of O2 min-1 mg protein-1) when compared to the H and control groups (S4: 23.09 ± 1.53, 17.04 ± 2.03, RCR: 3.15 ± 0.15, 3.68 ± 0.15 ng atoms of O2 min-1 mg protein-1, respectively), P < 0.05. Hepatic lipoperoxide concentrations were significantly increased and the concentration of reduced glutathione was significantly reduced in the CD group. A choline-deficient diet causes moderate steatosis with disruption of liver mitochondrial function and increased oxidative stress. These data suggest that lipid peroxidation products can impair the flow of electrons along the respiratory chain, causing overreduction of respiratory chain components and enhanced mitochondrial reactive oxygen species. These findings are important in the pathogenesis of nonalcoholic fatty liver disease

Liver mitochondrial dysfunction and oxidative stress in the pathogenesis of experimental nonalcoholic fatty liver disease

Oxidative stress and hepatic mitochondria play a role in the pathogenesis of nonalcoholic fatty liver disease. The aim of the present study was to evaluate the role of hepatic mitochondrial dysfunction and oxidative stress in the pathogenesis of the disease. Fatty liver was induced in Wistar rats with a choline-deficient diet (CD; N = 7) or a high-fat diet enriched with PUFAs-omega-3 (H; N = 7) for 4 weeks. The control group (N = 7) was fed a standard diet. Liver mitochondrial oxidation and phosphorylation were measured polarographically and oxidative stress was estimated on the basis of malondialdehyde and glutathione concentrations. Moderate macrovacuolar liver steatosis was observed in the CD group and mild liver steatosis was observed in the periportal area in the H group. There was an increase in the oxygen consumption rate by liver mitochondria in respiratory state 4 (S4) and a decrease in respiratory control rate (RCR) in the CD group (S4: 32.70 ± 3.35; RCR: 2.55 ± 0.15 ng atoms of O2 min-1 mg protein-1) when compared to the H and control groups (S4: 23.09 ± 1.53, 17.04 ± 2.03, RCR: 3.15 ± 0.15, 3.68 ± 0.15 ng atoms of O2 min-1 mg protein-1, respectively), P < 0.05. Hepatic lipoperoxide concentrations were significantly increased and the concentration of reduced glutathione was significantly reduced in the CD group. A choline-deficient diet causes moderate steatosis with disruption of liver mitochondrial function and increased oxidative stress. These data suggest that lipid peroxidation products can impair the flow of electrons along the respiratory chain, causing overreduction of respiratory chain components and enhanced mitochondrial reactive oxygen species. These findings are important in the pathogenesis of nonalcoholic fatty liver disease

Prevention and reversion of nonalcoholic steatohepatitis in ob/ob mice by S-nitroso-N-acetylcysteine treatment

To evaluate the role oral administration of S-nitroso-N-acetylcysteine (SNAC), a NO donor drug, in the prevention and reversion of NASH in two different animal models. Methods: NASH was induced in male ob/ob mice by methionine-choline deficient (MCD) and high-fat (H) diets. Two animal groups received or not SNAC orally for four weeks since the beginning of the treatment. Two other groups were submitted to MCD and H diets for 60 days receiving SNAC only from the 31st to the 60th day. Results: SNAC administration inhibited the development of NASH in all groups, leading to a marked decrease in macro and microvacuolar steatosis and in hepatic lipid peroxidation in the MCD group. SNAC treatment reversed the development of NASH in animals treated for 60 days with MCD or H diets, which received SNAC only from the 31st to the 60th day. Conclusions: Oral administration of SNAC markedly inhibited and reversed NASH induced by MCD and H diets in ob/ob mice.27229930

Oral Administration Of S-nitroso-n-acretylcysteine Prevents The Onset Of Non Alcoholic Fatty Liver Disease In Rats

Aim: To evaluate the potential of S-nitroso-N-acetyl-cysteine (SNAC) in inhibition of lipid peroxidation and the effect of oral SNAC administration in the prevention of nonalcoholic fatty liver disease (NAFLD) in an animal model. Methods: NAFLD was induced in Wistar male r ats by choline-deficient diet for 4 wk. SNAC-treated animals (n=6) (1.4 mg/kg/day of SNAC, orally) were compared to 2 control groups: one (n=6) received PBS solution and the other (n=6) received NAC solution (7 mg/kg/d). Histological variables were semiquantitated with respect to macro and microvacuolar fat changes, its zonal distribution, foci of necrosis, portal and perivenular fibrosis, and inflammatory infiltrate with zonal distribution. LOOHs from samples of liver homogenates were quantified by HPLC. Nitrate levels in plasma of portal vein were assessed by chemiluminescence. Aqueous low-density lipoprotein (LDL) suspensions (200 μg protein/mL) were incubated with CUCl2 (300 μmol/L) in the absence and presence of SNAC (300 μmol/L) for 15 h at 37 °C. Extent of LDL oxidation was assessed by fluorimetry. Linoleic acid (LA) (18.8 μmol/L) oxidation was induced by soybean lipoxygenase (SLO) (0.056 μmol/L at 37 °C in the presence and absence of N-acetylcysteine (NAQ and SNAC (56 and 560 μmol/L) and monitored at 234 nm. Results: Animals in the control group developed moderate macro and microvesicular fatty changes in periportal area. SNAC-treated animals displayed only discrete histological alterations with absence of fatty changes and did not develop liver steatosis. The absence of NAFLD in the SNAC-treated group was positively correlated with a decrease in the concentration of LOOH in liver homogenate, compared to the control group (0.7±0.2 nmol/mg vs 3.2±0.4 nmol/mg protein, respectively, P<0.05), while serum levels of aminotransferases were unaltered. The ability of SNAC in preventing lipid peroxidation was confirmed in in vitro experiments using LA and LDL as model substrates. Conclusion: Oral admi nistration of SNAC prevents the onset of NAFLD in Wistar rats fed with choline-deficient diet. This effect is correlated with the ability of SNAC to block the propagation of lipid peroxidation in vitro and in vitro. © 2006 The WJG Press. All rights reserved.121219051911McCullough, A.J., Update on nonalcoholic fatty liver disease (2002) J Clin Gastroenterol, 34, pp. 255-262Marchesini, G., Brizi, M., Morselli-Labate, A.M., Bianchi, G., Bugianesi, E., McCullough, A.J., Forlani, G., Melchionda, N., Association of nonalcoholic fatty liver disease with insulin resistance (1999) Am Med, 107, pp. 450-455Yang, S., Zhu, H., Li, Y., Lin, H., Gabrielson, K., Trush, M.A., Diehl, A.M., Mitochondrial adaptations to obesity-related oxidant stress (2000) Arch Biochem Biophys, 378, pp. 259-268Curzio, M., Esterbauer, H., Dianzani, M.U., Chernotactic activity of hydroxyalkenals on rat neutrophils (1985) Int J Tissue React, 7, pp. 137-142Lee, K.S., Buck, M., Houglum, K., Chojkier, M., Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression (1995) J Clin Invest, 96, pp. 2461-2468Robertson, G., Leclercq, I., Farrell, G.C., Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress (2001) Am J Physiol Gastrointest Liver Physiol, 281, pp. G1135-G1139Lapenna, D., Ciofani, G., Pierdomenico, S.D., Giamberardino, M.A., Cuccurullo, F., Dihydrolipoic acid inhibits 15-lipoxygenase-dependent lipid peroxidation (2003) Free Radic Biol Med, 35, pp. 1203-1209Kuhn, H., Borchert, A., Regulation of enzymatic lipid peroxidation: The interplay of peroxidizing and peroxide reducing enzymes (2002) Free Radic Biol Med, 33, pp. 154-172Patel, R.P., Levonen, A., Crawford, J.H., Darley-Usmar, V.M., Mechanisms of the pro- and anti-oxidant actions of nitric oxide in atherosclerosis (2000) Cardiovasc Res, 47, pp. 465-474Platis, I.E., Ermacora, M.R., Fox, R.O., Oxidative polypeptide cleavage mediated by EDTA-Fe covalently linked to cysteine residues (1993) Biochemistry, 32, pp. 12761-12767Rubbo, H., Darley-Usmar, V., Freeman, B.A., Nitric oxide regulation of tissue free radical injury (1996) Chem Res Toxicol, 9, pp. 809-820Hogg, N., Kalyanaraman, B., Nitric oxide and lipid peroxidation (1999) Biochim Biophys Acta, 1411, pp. 378-384Violi, F., Marino, R., Milite, M.T., Loffredo, L., Nitric oxide and its role in lipid peroxidation (1999) Diabetes Metab Res Rev, 15, pp. 283-288Giustarini, D., Milzani, A., Colombo, R., Dalle-Donne, I., Rossi, R., Nitric oxide and S-nitrosothiols in human blood (2003) Clin Chim Acta, 330, pp. 85-98Stamler, J.S., Singel, D.J., Loscalzo, J., Biochemistry of nitric oxide and its redox-activated forms (1992) Science, 258, pp. 1898-1902Jaworski, K., Kinard, F., Goldstein, D., Holvoet, P., Trouet, A., Schneider, Y.J., Remacle, C., S-nitrosothiols do not induce oxidative stress, contrary to other nitric oxide donors, in cultures of vascular enclothelial or smooth muscle cells (2001) Eur J Pharmacol, 425, pp. 11-19Ricardo, K.F., Shishido, S.M., de Oliveira, M.G., Krieger, M.H., Characterization of the hypotensive effect of S-nitroso-N-acetylcysteine in normotensive and hypertensive conscious rats (2002) Nitric Oxide, 7, pp. 57-66Von Sonntag, C., Free-radical reactions involving thiols and disulphides (1990) Sulfur-centered Reactive Intermediates in Chemistry and Biology., pp. 359-366. , C. Chatgilialoglu, K.-D. Asmus (Eds.), New York: Plenum PressWardman, P., von Sonntag, C., Kinetic factors that control the fate of thiyl radicals in cells (1995) Methods Enzymol, 251, pp. 31-45Kashyap, M.K., Yadav, V., Sherawat, B.S., Jain, S., Kumari, S., Khullar, M., Sharma, P.C., Nath, R., Different antioxidants status, total antioxidant power and free radicals in essential hypertension (2005) Mol Cell Biochem, 277, pp. 89-99Stocker, P., Lesgards, J.F., Vidal, N., Chalier, F., Prost, M., ESR study of a biological assay on whole blood: Antioxidant efficiency of various vitamins (2003) Biochim Biophys Acta, 1621, pp. 1-8Gilbert, B.C., Marshall, P.D.R., Norman, R.O.C., Pineda, N., Willians, P.S., Electron spin resonance studies. The generation and reactions of the t-butoxyl radical in aqueous solution (1981) J Chem Soc Perkin Trans II, 10, pp. 1392-1400Ewing, J.F., Janero, D.R., Specific S-nitrosothiol (thionitrite) quantification as solution nitrite after vanadium(III) reduction and ozone-chemiluminescent detection (1998) Free Radic Biol Med, 25, pp. 621-628Steinbrecher, U.P., Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products (1987) J Biol Chem, 262, pp. 3603-3608Rubbo, H., Trostchansky, A., Botti, K., Batthyany, C., Interactions of nitric oxide and peroxynitrite with low-density lipoprotein (2002) Biol Chem, 383, pp. 547-552Oliveira, C.P., da Costa Gayotto, L.C., Tatai, C., Della Bina, B.I., Janiszewski, M., Lima, E.S., Abdalla, D.S., Laudanna, A.A., Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet (2002) J Cell Mol Med, 6, pp. 399-406Kockx, M.M., De Meyer, G.R., Bortier, H., de Meyere, N., Muhring, J., Bakker, A., Jacob, W., Herman, A., Luminal foam cell accumulation is associated with smooth muscle cell death in the intimal thickening of human saphenous vein grafts (1996) Circulation, 94, pp. 1255-1262Yamamoto, Y., Brodsky, M.H., Baker, J.C., Ames, B.N., Detection and characterization of lipid hydroperoxides at picomole levels by high-performance liquid chromatography (1987) Anal Biochem, 160, pp. 7-13Koteish, A., Diehl, A.M., Animal models of steatosis (2001) Semin Liver Dis, 21, pp. 89-104Letteron, P., Fromenty, B., Terris, B., Degott, C., Pessayre, D., Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice (1996) J Hepatol, 24, pp. 200-208Grattagliano, I., Vendemiale, G., Caraceni, P., Domenicali, M., Nardo, B., Cavallari, A., Trevisani, F., Altomare, E., Starvation impairs antioxidant defense in fatty livers of rats fed a choline-deficient diet (2000) J Nutr, 130, pp. 2131-2136Padmaja, S., Huie, R.E., The reaction of nitric oxide with organic peroxyl radicals (1993) Biochem Biophys Res Commun, 195, pp. 539-544Napolitano, A., Camera, E., Picardo, M., d'Ishida, M., Reactions of hydro(pero)xy derivatives of polyunsaturated fatty acids /esters with nitrite ions under acidic conditions. Unusual nitrosative breakdown of methyl 13-hydro(pero)xyoctadeca-9,11-dienoate to a novel 4-nitro-2-oximinoalk-3-enal product (2002) J Org Chem, 67, pp. 1125-1132Rubbo, H., Radi, R., Trujillo, M., Telleri, R., Kalyanaraman, B., Barnes, S., Kirk, M., Freeman, B.A., Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives (1994) J Biol Chem, 269, pp. 26066-26075Lima, E.S., Di Mascio, P., Rubbo, H., Abdalla, D.S., Characterization of linoleic acid nitration in human blood plasma by mass spectrometry (2002) Biochemistry, 41, pp. 10717-10722Lima, E.S., Di Mascio, P., Abdalla, D.S., Cholesteryl nitrolinoleate, a nitrated lipid present in human blood plasma and lipoproteins (2003) J Lipid Res, 44, pp. 1660-1666de Oliveira, F.G., Rossi, C.L., de Oliveira, M.G., Saad, M.J., Velloso, L.A., Effect of vitamin E supplementation on antibody levels against malondialdehyde modified LDL in hyperlipidemic hamsters (2000) Cardiovasc Res, 47, pp. 567-573Hamilton, C.A., Low-density lipoprotein and oxidised low-density lipoprotein: Their role in the development of atherosclerosis (1997) Pharmacol Ther, 74, pp. 55-72de Oliveira, M.G., Shishido, S.M., Seabra, A.B., Morgon, N.H., Thermal stability of primary S-nitrosothiols: Roles of autocatalysis and structural effects on the rate of nitric oxide release (2002) J Phys Chem A, 106, pp. 8963-8970Oliveira, C.P., Gayotto, L.C., Tatai, C., Della Nina, B.I., Lima, E.S., Abdalla, D.S., Lopasso, F.P., Carrilho, F.J., Vitamin C and vitamin E in prevention of Nonalcoholic Fatty Liver Disease (NAFLD) in choline deficient diet fed rats (2003) Nutr J, 2, p. 9Senna, S.M., Moraes, R.B., Bravo, M.F., Oliveira, R.R., Miotto, G.C., Vidor, A.C., Bello-Klein, A., Homem de Bittencourt Jr., P.I., Effects of prostaglandins and nitric oxide on rat macrophage lipid metabolism in culture: Implications for arterial wall-leukocyte interplay in atherosclerosis (1998) Biochem Mol Biol Int, 46, pp. 1007-1018Krieger, M.H., Santos, K.F., Shishido, S.M., Wanschel, A.C., Estrela, H.F., Santos, L., De Oliveira, M.G., Laurindo, F.R., Antiatherogenic effects of S-nitroso-N-acetylcysteine in hypercholesterolemic LDL receptor knockout mice (2006) Nitric Oxide, 14, pp. 12-20Carvalho-Filho, M.A., Ueno, M., Hirabara, S.M., Seabra, A.B., Carvalheira, J.B., de Oliveira, M.G., Velloso, L.A., Saad, M.J., S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: A novel mechanism of insulin resistance (2005) Diabetes, 54, pp. 959-96

Modulation of hepatic microsomal triglyceride transfer protein (MTP) induced by S-nitroso-N-acetylcysteine in ob/ob mice

We evaluated the effects of a potent NO donor, S-nitroso-N-acetylcysteine (SNAC), on microsomal triglyceride transfer protein (MTP) expression in ob/ob mice. NAFLD was induced in male ob/ob mice using a methionine-choline deficient diet (MCD) concomitantly with oral SNAC fed solution (n = 5) or vehicle (control; n = 5) by gavage daily for 4 weeks. Livers were collected for histology and for assessing MTP by RT-qPCR, Western blot, immunohistochemistry and immunogold electron microscopy analyses. Histological analysis showed diffuse macro and microvesicular steatosis, moderate hepatocellular ballooning and moderate inflammatory infiltrate in ob/ob mice fed the MCD diet. With SNAC, mice showed a marked reduction in liver steatosis (p &lt; 0.01), in parenchymal inflammation (p = 0.02) and in MTP protein immunoexpression in zone III (p = 0.05). Moreover, SNAC caused reduction of MTP protein in Western blot analysis (p &lt; 0.05). In contrast, MTP mRNA content was significantly higher (p &lt; 0.05) in mice receiving SNAC. Immuno-electron microscopy showed MTP localized in the rough endoplasmic reticulum of hepatocytes in both treated and untreated groups. However with SNAC treatment, MTP was also observed surrounding fat globules. Histological improvement mediated by a nitric oxide donor is associated with significantly altered expression and distribution of MTP in this animal model of fatty liver disease. Further studies are in progress to examine possible mechanisms and to develop SNAC as a possible therapy for human fatty liver disease. © 2007 Elsevier Inc. All rights reserved